BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maor Y, Ergaz D, Malnick SDH, Melzer E, Neuman MG. Liraglutide-Induced Hepatotoxicity. Biomedicines 2021;9:106. [PMID: 33498980 DOI: 10.3390/biomedicines9020106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kong MW, Gao Y, Xie YY, Xing EH, Sun LX, Ma HJ, Xing HY. Mechanism of GLP-1 Receptor Agonists-Mediated Attenuation of Palmitic Acid-Induced Lipotoxicity in L6 Myoblasts. Biomed Res Int 2022;2022:6237405. [PMID: 36619308 DOI: 10.1155/2022/6237405] [Reference Citation Analysis]
2 Malnick SDH, Alin P, Somin M, Neuman MG. Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different. Int J Mol Sci 2022;23. [PMID: 36555867 DOI: 10.3390/ijms232416226] [Reference Citation Analysis]
3 Malnick S, Maor Y, Neuman MG. Green Tea Consumption Is Increasing but There Are Significant Hepatic Side Effects. GastroHep 2022;2022:1-5. [DOI: 10.1155/2022/2307486] [Reference Citation Analysis]
4 Shetty R, Basheer FT, Poojari PG, Thunga G, Chandran VP, Acharya LD. Adverse drug reactions of GLP-1 agonists: A systematic review of case reports. Diabetes Metab Syndr 2022;16:102427. [PMID: 35217468 DOI: 10.1016/j.dsx.2022.102427] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Clinton JW, Kiparizoska S, Aggarwal S, Woo S, Davis W, Lewis JH. Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature. Drug Saf 2021;44:1125-49. [PMID: 34533782 DOI: 10.1007/s40264-021-01109-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
6 Parvataneni S, Ramachandran R, Then E, Grantham T, Gaduputi V. An Exceedingly Rare Case of Liraglutide-Induced Liver Injury. Case Rep Gastrointest Med 2021;2021:6306149. [PMID: 34471551 DOI: 10.1155/2021/6306149] [Reference Citation Analysis]